AbbVie director awarded 62 stock equivalent units

AbbVie Inc. director Susan E. Quaggin reported a compensation-related award of stock equivalent units.

Rhea-AI Filing Summary

AbbVie Inc. director Susan E. Quaggin reported a compensation-related award of stock equivalent units. On the reported date, she acquired 62 stock equivalent units tied to AbbVie common stock at 251.64 per unit, bringing her total balance to 853 stock equivalent units held directly.

The footnotes explain that director fees are credited to an unfunded book account in the director's name and are distributed over a period equal to the director's years of board service, generally starting at the later of age 65 or retirement from the board. These stock equivalent units earn the same return as if the fees were invested in AbbVie stock and the reported balance also includes units acquired through a dividend reinvestment feature.

Insider Trade Summary

Grant/Award: 62 shares

Grant/Award 1 txn

Insider Quaggin Susan E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Equivalent Units	62	$251.64	$16K

Holdings After Transaction: Stock Equivalent Units — 853 contracts (Direct)

Footnotes (2)

1. F1. Director fees credited to an unfunded book account in the director's name are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock.
2. F2. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Key Figures

Stock equivalent units granted: 62 units Price per stock equivalent unit: 251.64 per unit Total stock equivalent units after transaction: 853 units +2 more

5 metrics

Stock equivalent units granted 62 units Grant/award acquisition on 2026-06-30

Price per stock equivalent unit 251.64 per unit Transaction price per unit for grant

Total stock equivalent units after transaction 853 units Balance following reported transaction

Transaction code A Grant, award, or other acquisition of derivative security

Transaction direction acquire Compensation-related award, not an open-market purchase

Key Terms

Stock Equivalent Units, unfunded book account, dividend reinvestment feature

3 terms

Stock Equivalent Units financial

"The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."

Stock equivalent units are financial claims or instruments that are treated as if they were actual shares for purposes like calculating ownership, dilution, and earnings per share. Think of them as promises or placeholders for future slices of company pie—options, restricted units, or convertible securities—that don’t yet sit on the table but will reduce each existing slice when converted. Investors track them because they change how much of a company each share really represents and can affect valuation and voting power.

unfunded book account financial

"Director fees credited to an unfunded book account in the director's name are distributed over a period equal to the director's years of board service"

dividend reinvestment feature financial

"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AbbVie (ABBV) director Susan E. Quaggin report?

Susan E. Quaggin reported an acquisition of stock equivalent units as director compensation. She received 62 stock equivalent units tied to AbbVie common stock, increasing her directly held balance to 853 units that track the economic return of AbbVie shares over time.

How many AbbVie stock equivalent units were granted in this Form 4 filing?

The filing shows a grant of 62 stock equivalent units to the director. These units are credited as part of director fees, mirror AbbVie stock performance, and contribute to a total balance of 853 stock equivalent units reported as directly held after the transaction.

What are stock equivalent units in AbbVie’s director compensation plan?

Stock equivalent units are bookkeeping entries that mirror AbbVie stock returns. Director fees are credited to an unfunded book account as these units, which earn the same return as if invested in AbbVie stock and may also grow through a dividend reinvestment feature described in the filing.

When are AbbVie director stock equivalent units distributed to Susan E. Quaggin?

The filing states that director fees credited as stock equivalent units are distributed over a period equal to the director’s years of board service. Distribution generally begins at the later of age 65 or retirement from the board, spreading payments over that service-based period.

Do AbbVie stock equivalent units include dividend reinvestment for directors?

Yes. The footnotes note that the reported balance includes stock equivalent units acquired through a dividend reinvestment feature. This means dividends that would be paid on AbbVie shares instead credit additional stock equivalent units to the director’s unfunded book account.

How many stock equivalent units does Susan E. Quaggin hold after this AbbVie transaction?

After the reported grant, Susan E. Quaggin holds 853 stock equivalent units directly. This total includes the newly awarded 62 units and prior units accumulated over time, including those gained through a dividend reinvestment feature tied to AbbVie stock performance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 05:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Quaggin Susan E

(Last) (First) (Middle)

1 N. WAUKEGAN ROAD

(Street)

NORTH CHICAGO ILLINOIS 60064

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AbbVie Inc. [ ABBV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Equivalent Units	$251.64	06/30/2026		A		62		(1)	(1)	Common Stock	62	$251.64	853(2)	D

Explanation of Responses:

1. Director fees credited to an unfunded book account in the director's name are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock.

2. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

	/s/ T.O. Odutayo, Attorney-in-Fact for Susan E. Quaggin	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)